Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
CLO & Secretary
-
Stock Symbol
-
LGND on Nasdaq, LGNDZ, LGNXZ, LGNYZ, LGNZZ on OTC
Andrew Reardon - trading volume in the past year for Ligand Pharmaceuticals Inc
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
22.5K |
$2.4M |
$106.39 |
Aug 28, 2024 |
Direct |
|
|
| Non-Qualified Stock Option (right to buy) |
62.9K |
|
|
May 9, 2024 |
Direct |
Common Stock |
|
| Non-Qualified Stock Option (right to buy) |
61.4K |
|
|
Aug 28, 2024 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.